Assembly Biosciences
ASMB
50 hedge funds and large institutions have $27.2M invested in Assembly Biosciences in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 22 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.12% less ownership
Funds ownership: 2.97% → 2.86% (-0.12%)
7% less funds holding
Funds holding: 54 → 50 (-4)
25% less capital invested
Capital invested by funds: $36.1M → $27.2M (-$8.88M)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
55% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.15M |
| 2 |
Millennium Management
New York
|
+$259K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$119K |
| 4 |
Renaissance Technologies
New York
|
+$111K |
| 5 |
VF
Virtu Financial
New York
|
+$60.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$869K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$544K |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$284K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$281K |
| 5 |
Barclays
London,
United Kingdom
|
-$249K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
51
HRT Financial
New York
| – | -$44K | -1,753 | Closed |
|
|
EGM
52
Engineers Gate Manager
New York
| – | -$40K | -1,595 | Closed |
|
|
XT
53
XTX Topco
George Town,
Cayman Islands
| – | -$28K | -1,101 | Closed |
|
54
Ameriprise
Minneapolis,
Minnesota
| – | -$21K | -845 | Closed |
|
|
KAM
55
Krensavage Asset Management
New York
| – | -$21K | -832 | Closed |
|
56
JP Morgan Chase
New York
| – | -$12.6K | -519 | -98% |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$387 | +16 | New |
|
ASMB Hedge Fund Activity: Q3 2022 in Review
50 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2022, worth a combined $27.2M — down 25% from $36.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ASMB and 4 opened new positions — a net loss of 4 holders — while 22 trimmed existing stakes and 10 added.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $1.15M. The largest seller was Assenagon Asset Management, cutting an estimated $869K.
- 50 institutional investors held Assembly Biosciences (ASMB) as of Q3 2022, down from 54 in Q2 2022.
- Funds reported $27.2M of Assembly Biosciences stock for Q3 2022, down 25% quarter-over-quarter.
- 4 funds opened new Assembly Biosciences positions in Q3 2022 and 8 closed out, a net change of -4 holders.
- The largest Assembly Biosciences buyer in Q3 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.15M added.
- The largest Assembly Biosciences seller in Q3 2022 was Assenagon Asset Management, an estimated $869K sold.
Based on aggregated 13F filings for Q3 2022.